Interleukin-4 and Interleukin-13 signaling
Busch-Dienstfertig M, González-Rodríguez S. IL-4, JAK-STAT signaling, and pain. JAKSTAT. 2013 Oct 01;2(4):e27638. PMID: 24470980; PMCID: PMC3897502.; Bhattacharjee A, Shukla M, Yakubenko VP, Mulya A, Kundu S, Cathcart MK. IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radical Biology and Medicine. 2013 Jan;54():1–16. doi: 10.1016/j.freeradbiomed.2012.10.553.; Busch-Dienstfertig M, Labuz D, Wolfram T, Vogel NN, Stein C. JAK-STAT1/3-induced expression of signal sequence-encoding proopiomelanocortin mRNA in lymphocytes reduces inflammatory pain in rats. Molecular Pain. 2012 Jan 01;8(1):83. doi: 10.1186/1744-8069-8-83.; Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010 May 28;32(5):593–604. doi: 10.1016/j.immuni.2010.05.007. PMID: 20510870.; LaPorte SL, Juo ZS, Vaclavikova J, Colf LA, Qi X, Heller NM, Keegan AD, Garcia KC. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell. 2008 Jan 25;132(2):259–72. PMID: 18243101; PMCID: PMC2265076.; Ratthé C, Pelletier M, Chiasson S, Girard D. Molecular mechanisms involved in interleukin-4-induced human neutrophils: expression and regulation of suppressor of cytokine signaling. J Leukoc Biol. 2007 May;81(5):1287–96. doi: 10.1189/jlb.0306209. PMID: 17264307.; Andrews AL, Holloway JW, Holgate ST, Davies DE. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets. J Immunol. 2006 Jun 15;176(12):7456–61. doi: 10.4049/jimmunol.176.12.7456. PMID: 16751391.; Börner C, Wöltje M, Höllt V, Kraus J. STAT6 transcription factor binding sites with mismatches within the canonical 5'-TTC...GAA-3' motif involved in regulation of delta- and mu-opioid receptors. J Neurochem. 2004 Dec;91(6):1493–500. doi: 10.1111/j.1471-4159.2004.02846.x. PMID: 15584925.; Hershey GK. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol. 2003 Apr;111(4):677–90; quiz 691. doi: 10.1067/mai.2003.1333. PMID: 12704343.; Roy B, Bhattacharjee A, Xu B, Ford D, Maizel AL, Cathcart MK. IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats. J Leukoc Biol. 2002 Sep;72(3):580–9. PMID: 12223527.; Loke P, Nair MG, Parkinson J, Guiliano D, Blaxter M, Allen JE. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol. 2002 Jul 04;3():7. PMID: 12098359; PMCID: PMC117781.; Kraus J, Börner C, Giannini E, Hickfang K, Braun H, Mayer P, Hoehe MR, Ambrosch A, König W, Höllt V. Regulation of µ-Opioid Receptor Gene Transcription by Interleukin-4 and Influence of an Allelic Variation within a STAT6 Transcription Factor Binding Site. Journal of Biological Chemistry. 2001 Nov;276(47):43901–8. doi: 10.1074/jbc.m107543200.; Umeshita-Suyama R, Sugimoto R, Akaiwa M, Arima K, Yu B, Wada M, Kuwano M, Nakajima K, Hamasaki N, Izuhara K. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation. Int Immunol. 2000 Nov;12(11):1499–509. doi: 10.1093/intimm/12.11.1499. PMID: 11058569.; Hage T, Sebald W, Reinemer P. Crystal structure of the interleukin-4/receptor alpha chain complex reveals a mosaic binding interface. Cell. 1999 Apr 16;97(2):271–81. doi: 10.1016/s0092-8674(00)80736-9. PMID: 10219247.; Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999;17():701–38. doi: 10.1146/annurev.immunol.17.1.701. PMID: 10358772.; Roy B, Cathcart MK. Induction of 15-Lipoxygenase Expression by IL-13 Requires Tyrosine Phosphorylation of Jak2 and Tyk2 in Human Monocytes. Journal of Biological Chemistry. 1998 Nov;273(48):32023–9. doi: 10.1074/jbc.273.48.32023.; Donaldson DD, Whitters MJ, Fitz LJ, Neben TY, Finnerty H, Henderson SL, O'Hara RM, Beier DR, Turner KJ, Wood CR, Collins M. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol. 1998 Sep 01;161(5):2317–24. PMID: 9725226.; Leonard WJ, O'Shea JJ. Jaks and STATs: biological implications. Annu Rev Immunol. 1998;16():293–322. doi: 10.1146/annurev.immunol.16.1.293. PMID: 9597132.; Zhang JG, Hilton DJ, Willson TA, McFarlane C, Roberts BA, Moritz RL, Simpson RJ, Alexander WS, Metcalf D, Nicola NA. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains. J Biol Chem. 1997 Apr 04;272(14):9474–80. doi: 10.1074/jbc.272.14.9474. PMID: 9083087.; Miloux B, Laurent P, Bonnin O, Lupker J, Caput D, Vita N, Ferrara P. Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett. 1997 Jan 20;401(2-3):163–6. doi: 10.1016/s0014-5793(96)01462-7. PMID: 9013879.; Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ. cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem. 1996 Nov 15;271(46):29265–70. doi: 10.1074/jbc.271.46.29265. PMID: 8910586.; Shen BJ, Hage T, Sebald W. Global and local determinants for the kinetics of interleukin-4/interleukin-4 receptor alpha chain interaction. A biosensor study employing recombinant interleukin-4-binding protein. Eur J Biochem. 1996 Aug 15;240(1):252–61. doi: 10.1111/j.1432-1033.1996.0252h.x. PMID: 8797861.; Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S. Essential role of Stat6 in IL-4 signalling. Nature. 1996 Apr 18;380(6575):627–30. doi: 10.1038/380627a0. PMID: 8602263.; Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. U.S.A. 1996 Jan 09;93(1):497–501. doi: 10.1073/pnas.93.1.497.; Obiri NI, Debinski W, Leonard WJ, Puri RK. Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15. J Biol Chem. 1995 Apr 14;270(15):8797–804. doi: 10.1074/jbc.270.15.8797. PMID: 7721786.; Hoffman RC, Castner BJ, Gerhart M, Gibson MG, Rasmussen BD, March CJ, Weatherbee J, Tsang M, Gustchina A, Schalk-Hihi C, Reshetnikova L, Wlodawer A. Direct evidence of a heterotrimeric complex of human interleukin-4 with its receptors. Protein Science. 1995 Mar;4(3):382–6. doi: 10.1002/pro.5560040304.; Boussiotis VA, Barber DL, Nakarai T, Freeman GJ, Gribben JG, Bernstein GM, D'Andrea AD, Ritz J, Nadler LM. Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science. 1994 Nov 11;266(5187):1039–42. doi: 10.1126/science.7973657. PMID: 7973657.; Russell SM, Johnston JA, Noguchi M, Kawamura M, Bacon CM, Friedmann M, Berg M, McVicar DW, Witthuhn BA, Silvennoinen O, Goldman AS, Schmalstieg FC, Ihle JN, O'Shea JJ, Leonard WJ. Interaction of IL-2Rß and ? c Chains with Jak1 and Jak3: Implications for XSCID and XCID. Science. 1994 Nov 11;266(5187):1042–5. doi: 10.1126/science.7973658.; Yin T, Tsang ML, Yang YC. JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes. Journal of Biological Chemistry. 1994 Oct;269(43):26614–7. doi: 10.1016/s0021-9258(18)47061-5.; Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature. 1994 Jul 14;370(6485):153–7. doi: 10.1038/370153a0. PMID: 8022486.